Eliana Bignotti
Brescia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Response to Correspondence of Cheng W. et al. on "Decoding BRCA1 and BRCA2 mutations in high-grade serous ovarian cancer: impact of location and type of mutation on prognosis and PARP inhibitor treatment" by Momi M. et al.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: July 07, 2026
Integrated mutational landscape analysis of endometrial stromal sarcoma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 27, 2026
Decoding BRCA1 and BRCA2 Mutations in High-Grade Serous Ovarian Cancer: Impact of Location and Type of Mutation on Prognosis and PARP Inhibitor Treatment.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: November 27, 2025
Clinical Significance of Soluble L1CAM Serum Levels in Patients with High-Risk Endometrial Cancer.
Journal: Biomedicines
Published: September 08, 2025
Serum miRNA-based diagnostic models for endometriosis: from discovery to validation.
Journal: Human reproduction (Oxford, England)
Published: May 22, 2025
Oxford Classic-Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 17, 2024
Impact of metabolism-related markers on outcomes in ovarian cancer patients: Findings of the MITO16A/MaNGO-OV2 trial.
Journal: The International journal of biological markers
Published: November 08, 2024
Circulating Serum Micro-RNA as Non-Invasive Diagnostic Biomarkers of Endometriosis.
Journal: Biomedicines
Published: October 03, 2024
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 16, 2024
Hormone Receptor Expression and Activity for Different Tumour Locations in Patients with Advanced and Recurrent Endometrial Carcinoma.
Journal: Cancers
Published: April 15, 2024
TP53 mutations and survival in ovarian carcinoma patients receiving first-line chemotherapy plus bevacizumab: Results of the MITO16A/MaNGO OV-2 study.
Journal: International journal of cancer
Published: December 22, 2023
Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer.
Journal: Gynecologic oncology
Published: December 04, 2023
Last Updated: 09/26/2026